Literature DB >> 19297472

High-throughput cell-based screen for chemicals that inhibit infection by simian virus 40 and human polyomaviruses.

Edward C Goodwin1, Walter J Atwood, Daniel DiMaio.   

Abstract

We developed a high-throughput, cell-based screen to identify chemicals that inhibit infection by the primate polyomaviruses. The screen is based on the detection of compounds that inhibit the ability of a replication-defective simian virus 40 (SV40)-based viral vector to cause growth arrest in HeLa cells by repressing the expression of the endogenous human papillomavirus E7 oncogene in these cells. We identified two compounds, ellagic acid and spiperone, that suppressed the ability of the SV40 recombinant virus to inhibit cellular DNA synthesis. These compounds caused a marked reduction of the ability of wild-type SV40 to productively infect permissive monkey cells, even when the compounds were added several hours after infection. The fraction of cells expressing SV40 large T antigen and the levels of T antigen mRNA were reduced in infected human and monkey cells treated with ellagic acid and spiperone, suggesting that these compounds block a step in the virus life cycle prior to SV40 early gene expression. Ellagic acid and spiperone also inhibited large T antigen expression by BK virus and JC virus, two important, pathogenic human polyomaviruses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19297472      PMCID: PMC2681952          DOI: 10.1128/JVI.00203-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

2.  Propagation and assay of BK virus.

Authors:  W A Knowles
Journal:  Methods Mol Biol       Date:  2001

3.  Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae.

Authors:  H A Anderson; Y Chen; L C Norkin
Journal:  Mol Biol Cell       Date:  1996-11       Impact factor: 4.138

Review 4.  BK virus, JC virus and Simian Virus 40 infection in humans, and association with human tumors.

Authors:  Giuseppe Barbanti-Brodano; Silvia Sabbioni; Fernanda Martini; Massimo Negrini; Alfredo Corallini; Mauro Tognon
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

5.  Cancer. A skin cancer virus?

Authors:  Raphael P Viscidi; Keerti V Shah
Journal:  Science       Date:  2008-02-22       Impact factor: 47.728

6.  Efficient transactivation and morphologic transformation by bovine papillomavirus genes expressed from a bovine papillomavirus/simian virus 40 recombinant virus.

Authors:  J Settleman; D DiMaio
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

7.  Bovine papillomavirus E2 protein activates a complex growth-inhibitory program in p53-negative HT-3 cervical carcinoma cells that includes repression of cyclin A and cdc25A phosphatase genes and accumulation of hypophosphorylated retinoblastoma protein.

Authors:  L K Naeger; E C Goodwin; E S Hwang; R A DeFilippis; H Zhang; D DiMaio
Journal:  Cell Growth Differ       Date:  1999-06

8.  HIV type 1 infection of human astrocytes is restricted by inefficient viral entry.

Authors:  B Schweighardt; W J Atwood
Journal:  AIDS Res Hum Retroviruses       Date:  2001-08-10       Impact factor: 2.205

9.  Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER.

Authors:  L Pelkmans; J Kartenbeck; A Helenius
Journal:  Nat Cell Biol       Date:  2001-05       Impact factor: 28.824

Review 10.  Genetic diversity-independent neutralization of pandemic viruses (e.g. HIV), potentially pandemic (e.g. H5N1 strain of influenza) and carcinogenic (e.g. HBV and HCV) viruses and possible agents of bioterrorism (variola) by enveloped virus neutralizing compounds (EVNCs).

Authors:  Girish J Kotwal
Journal:  Vaccine       Date:  2007-12-26       Impact factor: 3.641

View more
  11 in total

1.  A screen for modulators of large T antigen's ATPase activity uncovers novel inhibitors of Simian Virus 40 and BK virus replication.

Authors:  Sandlin P Seguin; Alex W Ireland; Tushar Gupta; Christine M Wright; Yoshinari Miyata; Peter Wipf; James M Pipas; Jason E Gestwicki; Jeffrey L Brodsky
Journal:  Antiviral Res       Date:  2012-08-07       Impact factor: 5.970

2.  Synthesis and structure–activity relationships of small molecule inhibitors of the simian virus 40 T antigen oncoprotein, an anti-polyomaviral target.

Authors:  Alex W Ireland; Theodore A Gobillot; Tushar Gupta; Sandlin P Seguin; Mary Liang; Lynn Resnick; Margot T Goldberg; Alexandra Manos-Turvey; James M Pipas; Peter Wipf; Jeffrey L Brodsky
Journal:  Bioorg Med Chem       Date:  2014-11-15       Impact factor: 3.641

3.  Dihydropyrimidinones and -thiones with improved activity against human polyomavirus family members.

Authors:  Alexandra Manos-Turvey; Hiba A Al-Ashtal; Patrick G Needham; Caroll B Hartline; Mark N Prichard; Peter Wipf; Jeffrey L Brodsky
Journal:  Bioorg Med Chem Lett       Date:  2016-08-25       Impact factor: 2.823

4.  Search, Identification, and Design of Effective Antiviral Drugs Against Pandemic Human Coronaviruses.

Authors:  Tianguang Huang; Lin Sun; Dongwei Kang; Vasanthanathan Poongavanam; Xinyong Liu; Peng Zhan; Luis Menéndez-Arias
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  The Effects of Ellagic Acid upon Brain Cells: A Mechanistic View and Future Directions.

Authors:  Marcos Roberto de Oliveira
Journal:  Neurochem Res       Date:  2016-02-04       Impact factor: 3.996

6.  Ellagic acid plays a protective role against UV-B-induced oxidative stress by up-regulating antioxidant components in human dermal fibroblasts.

Authors:  Beomyeol Baek; Su Hee Lee; Kyunghoon Kim; Hye-Won Lim; Chang-Jin Lim
Journal:  Korean J Physiol Pharmacol       Date:  2016-04-26       Impact factor: 2.016

7.  Improvement of the functionality of pancreatic Langerhans islets via reduction of bacterial contamination and apoptosis using phenolic compounds.

Authors:  Mahban Rahimifard; Shermineh Moini-Nodeh; Kamal Niaz; Maryam Baeeri; Hossein Jamalifar; Mohammad Abdollahi
Journal:  Iran J Basic Med Sci       Date:  2018-09       Impact factor: 2.699

Review 8.  Neuroprotective Potential of Ellagic Acid: A Critical Review.

Authors:  Ashutosh Gupta; Amit Kumar Singh; Ramesh Kumar; Sarah Jamieson; Abhay Kumar Pandey; Anupam Bishayee
Journal:  Adv Nutr       Date:  2021-07-30       Impact factor: 8.701

Review 9.  Recent advances in developing small-molecule inhibitors against SARS-CoV-2.

Authors:  Rong Xiang; Zhengsen Yu; Yang Wang; Lili Wang; Shanshan Huo; Yanbai Li; Ruiying Liang; Qinghong Hao; Tianlei Ying; Yaning Gao; Fei Yu; Shibo Jiang
Journal:  Acta Pharm Sin B       Date:  2021-07-02       Impact factor: 14.903

10.  Comprehensive Consensus Analysis of SARS-CoV-2 Drug Repurposing Campaigns.

Authors:  Hazem Mslati; Francesco Gentile; Carl Perez; Artem Cherkasov
Journal:  J Chem Inf Model       Date:  2021-07-27       Impact factor: 4.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.